F. Joseph Loughrey - Feb 10, 2022 Form 4 Insider Report for Hillenbrand, Inc. (HI)

Role: Director
Signature: /s/ Sarah A. Tarkington as Attorney-in-Fact for F. Joseph Loughrey
Stock symbol: HI
Transactions as of: Feb 10, 2022
Transactions value $: $0
Form type: 4
Date filed: 2/11/2022, 03:10 PM
Previous filing: Jan 4, 2022
Next filing: Apr 1, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	HI	Common Stock						30K	Feb 10, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HI	Restricted Stock Units (Deferred Stock Award) 2/10/22	Award	$0	+4.39K		$0.00	4.39K	Feb 10, 2022	Common Stock	4.39K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Conversion or Exercise Price of Derivative Securities is 1-for-1.
F2	These stock units vest on the earlier to occur of the issuer's next annual meeting of shareholders or one year from the date of grant; provided, that these stock units will immediately vest upon, and in any case delivery of the shares underlying these stock units will not occur until, the occurrence of one of the following: a change in control of the issuer, the director's death or permanent and total disability, or one day after the date the director ceases to be a director of the issuer.

Content

Conversion or Exercise Price of Derivative Securities is 1-for-1.

These stock units vest on the earlier to occur of the issuer's next annual meeting of shareholders or one year from the date of grant; provided, that these stock units will immediately vest upon, and in any case delivery of the shares underlying these stock units will not occur until, the occurrence of one of the following: a change in control of the issuer, the director's death or permanent and total disability, or one day after the date the director ceases to be a director of the issuer.